422 related articles for article (PubMed ID: 8162713)
61. Immediate postabortal insertion of intrauterine devices.
Grimes D; Schulz K; Stanwood N
Cochrane Database Syst Rev; 2002; (3):CD001777. PubMed ID: 12137634
[TBL] [Abstract][Full Text] [Related]
62. Past use of an intrauterine device and risk of tubal pregnancy.
Rossing MA; Daling JR; Weiss NS; Voigt LF; Stergachis AS; Wang SP; Grayston JT
Epidemiology; 1993 May; 4(3):245-51. PubMed ID: 8512988
[TBL] [Abstract][Full Text] [Related]
63. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
64. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
65. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
Lavin P; Waszak C; Bravo C
Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
[TBL] [Abstract][Full Text] [Related]
66. [Health risks of intrauterine contraception (author's transl)].
Keith LG; Berger GS; Edelman DA
Contracept Fertil Sex (Paris); 1983 Jun; 11(6):801-8. PubMed ID: 12338737
[TBL] [Abstract][Full Text] [Related]
67. [IUDs and ectopic pregnancy].
Sivin I
Contracept Fertil Sex (Paris); 1983 Dec; 11(12):1287-94. PubMed ID: 12312723
[TBL] [Abstract][Full Text] [Related]
68. Intrauterine devices.
Mccarthy TG; Ratnam SS
Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
[TBL] [Abstract][Full Text] [Related]
69. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
70. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
71. [The effect of intrauterine contraceptive devices on the endometrium].
Sheppard BL; Bonnar J
Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
[TBL] [Abstract][Full Text] [Related]
72. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
73. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
Newton J; Szontagh F; Lebech P; Rowe P
Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
[TBL] [Abstract][Full Text] [Related]
74. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
[TBL] [Abstract][Full Text] [Related]
75. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
76. Actinomyces-like structures and their association with intrauterine contraceptive devices, pelvic infection and abnormal cervical cytology.
Sykes GS; Shelley G
Br J Obstet Gynaecol; 1981 Sep; 88(9):934-7. PubMed ID: 7272267
[TBL] [Abstract][Full Text] [Related]
77. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
78. Cytopathological changes in human cervix and endometrium following prolonged retention of copper-bearing intrauterine contraceptive devices.
Misra JS; Engineer AD; Tandon P
Diagn Cytopathol; 1989; 5(3):237-42. PubMed ID: 2791830
[TBL] [Abstract][Full Text] [Related]
79. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
80. [Clinical study of intrauterine contraceptives].
Parshina LA; Konishcheva OE
Akush Ginekol (Mosk); 1977 Dec; (12):39-40. PubMed ID: 605979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
